Keratinocytes are a major cell type in the epidermis. However, keratin proliferation and dysregulation can lead to many keratin associated diseases or disorders, including hyperproliferative skin disorders such as psoriasis, eczema, and keratosis, scaring or suboptimal wound healing. Faculty members at the University of Texas Health Science Center at Houston have developed a novel method and composition for the treatment of keratin associated hyperproliferative conditions in mammals comprising of amniotic fluid, or purified derivatives thereof, that selectively inhibit keratinocyte proliferation by inducing differentiation.
Inventors:
Loveprett K. Mann
Ramesha Papanna
Jong Hak Won
Intellectual Property Status:
This technology has a pending patent application and is available for licensing.